These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26666910)

  • 21. Lipegfilgrastim for the prophylaxis and treatment of chemotherapy-induced neutropenia.
    Ratti M; Tomasello G
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):15-24. PubMed ID: 25409861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antineoplastic drug-induced neutropenia: use of granulocyte colony stimulating factors].
    Carrato A; Guillén-Ponce C; Grande-Pulido E
    Farm Hosp; 2010 Mar; 34 Suppl 1():8-11. PubMed ID: 20920851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maximizing the outcomes in cancer patients receiving chemotherapy through optimal use of colony-stimulating factor.
    Mucenski JW; Shogan JE
    J Manag Care Pharm; 2003; 9(2 Suppl):10-4. PubMed ID: 14613339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pustular eruption associated with granulocyte colony-stimulating factor treatment.
    Brumana MB; Russo I; Zambello R; Alaibac M
    G Ital Dermatol Venereol; 2018 Apr; 153(2):276-277. PubMed ID: 27845511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of filgrastim and pegfilgrastim as primary prophylaxis against febrile neutropenia in lymphoma patients.
    Lathia N; Isogai PK; De Angelis C; Smith TJ; Cheung M; Mittmann N; Hoch JS; Walker S
    J Natl Cancer Inst; 2013 Aug; 105(15):1078-85. PubMed ID: 23873405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk assessment and guidelines for first-cycle colony-stimulating factor use in the management of chemotherapy-induced neutropenia.
    Crawford J
    Oncology (Williston Park); 2006 Apr; 20(5 Suppl 4):22-8. PubMed ID: 16736985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegfilgrastim use during chemotherapy: current and future applications.
    Wolf T; Densmore JJ
    Curr Hematol Rep; 2004 Nov; 3(6):419-23. PubMed ID: 15496275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pegfilgrastim prophylaxis in patients at different levels of risk for chemotherapy-associated febrile neutropenia: an observational study.
    Fiegl M; Steger GG; Studnicka M; Eisterer W; Jaeger C; Willenbacher W
    Curr Med Res Opin; 2013 May; 29(5):505-15. PubMed ID: 23444969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose continuous subcutaneous infusion of granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in acute myelogenous leukemia and its pharmacokinetics.
    Ikeda K; Tasaka T; Sasaki K; Murata M; Kitanaka A; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1994 Nov; 8(11):1838-41. PubMed ID: 7526087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule.
    Derbel O; Cannas G; Le QH; Elhamri M; Chelghoum Y; Nicolas-Virelizier E; Nicolini F; Troncy J; Barraco F; Michallet M; Thomas X
    Hematology; 2010 Jun; 15(3):125-31. PubMed ID: 20557669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different schedules of granulocyte growth factor support for patients with breast cancer receiving adjuvant dose-dense chemotherapy: a prospective nonrandomized study.
    Hendler D; Rizel S; Yerushalmi R; Neiman V; Bonilla L; Braunstein R; Sulkes A; Stemmer SM
    Am J Clin Oncol; 2011 Dec; 34(6):619-24. PubMed ID: 21217400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.
    Bradley AM; Deal AM; Buie LW; van Deventer H
    Pharmacotherapy; 2012 Dec; 32(12):1070-7. PubMed ID: 23208834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent G-CSF and chemotherapy.
    Livingston RB
    J Clin Oncol; 1998 Dec; 16(12):3917. PubMed ID: 9850040
    [No Abstract]   [Full Text] [Related]  

  • 35. Retrospective comparison of neutropenia in children with Ewing sarcoma treated with chemotherapy and granulocyte colony-stimulating factor (G-CSF) or pegylated G-CSF.
    Milano-Bausset E; Gaudart J; Rome A; Coze C; Gentet JC; Padovani L; Lacarelle B; André N
    Clin Ther; 2009; 31 Pt 2():2388-95. PubMed ID: 20110048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study.
    Jolis L; Carabantes F; Pernas S; Cantos B; López A; Torres P; Funes C; Caballero D; Benedit P; Salar A;
    Eur J Cancer Care (Engl); 2013 Jul; 22(4):513-21. PubMed ID: 23730920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.
    Rifkin R; Spitzer G; Orloff G; Mandanas R; McGaughey D; Zhan F; Boehm KA; Asmar L; Beveridge R
    Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):186-91. PubMed ID: 20511163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective study of patients' out-of-pocket costs for granulocyte colony-stimulating factors.
    Tomic K; Long S; Li X; Fu AC; Yu TC; Barron R
    J Oncol Pharm Pract; 2013 Dec; 19(4):328-37. PubMed ID: 23353712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Growth factors in oncology: effectiveness and prospects].
    Ottmann OG; Hoelzer D
    Praxis (Bern 1994); 1998 Sep; 87(36):1153-9. PubMed ID: 9782744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pegfilgrastim-induced pain in patients with lymphoma.
    Mullen EC
    Oncol Nurs Forum; 2014 Mar; 41(2):212-4. PubMed ID: 24578081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.